Clinical Trial: Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807423) titled 'Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.' on Sept. 01.

Brief Summary: DISPLAY-AF is a prospective, multicenter, single-arm post-market clinical follow-up investigation designed to evaluate whether spatiotemporal dispersion areas identified by the Volta AF-Xplorer II artificial intelligence (AI) software can predict recurrence of atrial arrhythmias after pulmonary vein isolation (PVI)-only ablation in patients with persistent atrial fibrillation.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Persitent Atrial Fib...